News & Media

Recent Press Releases

Five Prime Presents on Novel B7-H4 Therapeutic Antibody at the 2018 AACR Annual Meeting
April 15, 2018

Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Trial of Novel First-in-Class B7-H4 Antibody FPA150
March 28, 2018

Five Prime Therapeutics Announces Oral Presentation on FPA150 at the 2018 AACR Annual Meeting
March 27, 2018

Contact Us

For more information please contact Five Prime Media Relations at:

111 Oyster Point Boulevard
South San Francisco, CA 94080
Main: 415-365-5600
Fax: 415-365-5601

pr@fiveprime.com